4.7 Article

OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome

期刊

CELL STEM CELL
卷 24, 期 6, 页码 908-+

出版社

CELL PRESS
DOI: 10.1016/j.stem.2019.04.014

关键词

-

资金

  1. NIH [R21HD091512, R01NS102382]
  2. NIH (Institutional Development Award from the National Institute of General Medical Sciences [NIGMS]) [P30GM110768]
  3. Edna Ittner Pediatric Research Support Fund
  4. Memorial Hermann Foundation-Staman Ogilvie Fund
  5. Bentsen Stroke Center
  6. TIRR Foundation through Mission Connect [014-115]
  7. Craig H. Neilsen Foundation [338617]
  8. [R01NS110707]
  9. [R21NS097992]
  10. [R01AA023797]
  11. [R01ES026057]
  12. [R01AT009152]
  13. [R21DA039686]

向作者/读者索取更多资源

Down syndrome (DS) is a common neurodevelopmental disorder, and cognitive defects in DS patients may arise from imbalances in excitatory and inhibitory neurotransmission. Understanding the mechanisms underlying such imbalances may provide opportunities for therapeutic intervention. Here, we show that human induced pluripotent stem cells (hiPSCs) derived from DS patients overproduce OLIG2(+) ventral forebrain neural progenitors. As a result, DS hiPSC-derived cerebral organoids excessively produce specific subclasses of GABAergic interneurons and cause impaired recognition memory in neuronal chimeric mice. Increased OLIG2 expression in DS cells directly upregulates interneuron line-age-determining transcription factors. shRNA-mediated knockdown of OLIG2 largely reverses abnormal gene expression in early-stage DS neural progenitors, reduces interneuron production in DS organoids and chimeric mouse brains, and improves behavioral deficits in DS chimeric mice. Thus, altered OLIG2 expression may underlie neurodevelopmental abnormalities and cognitive defects in DS patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据